UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

JAK inhibitors in COVID-19: need for vigilance regarding increased inherent thrombotic risk

Mehta, P; Ciurtin, C; Scully, M; Levi, M; Chambers, RC; (2020) JAK inhibitors in COVID-19: need for vigilance regarding increased inherent thrombotic risk. European Respiratory Journal , 56 (3) , Article 2001919. 10.1183/13993003.01919-2020. Green open access

[thumbnail of Chambers_2001919.full.pdf]
Preview
Text
Chambers_2001919.full.pdf - Published Version

Download (383kB) | Preview
Type: Article
Title: JAK inhibitors in COVID-19: need for vigilance regarding increased inherent thrombotic risk
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1183/13993003.01919-2020
Publisher version: https://doi.org/10.1183/13993003.01919-2020
Language: English
Additional information: © ERS 2020 This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0 (https://creativecommons.org/licenses/by-nc/4.0/).
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Respiratory Medicine
URI: https://discovery.ucl.ac.uk/id/eprint/10105456
Downloads since deposit
30Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item